These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779 [TBL] [Abstract][Full Text] [Related]
7. Eplerenone's role in the management of complex cardiovascular disorders. Stewart Coats AJ; Shewan L Int J Cardiol; 2015 Dec; 200():1-2. PubMed ID: 26116081 [TBL] [Abstract][Full Text] [Related]
8. Effects of eplerenone on P-wave signal-averaged electrocardiogram in hypertensive patients with coronary artery disease. Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Higaki T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Kihara Y Int J Cardiol; 2014; 172(1):e180-1. PubMed ID: 24439863 [No Abstract] [Full Text] [Related]
9. Eplerenone treatment of aortic stenosis. [letter]. Marciniak TA Am Heart J; 2009 Mar; 157(3):e15; author reply e17. PubMed ID: 19249405 [No Abstract] [Full Text] [Related]
10. Effects of a beta-blocker and spironolactone on plasma homocysteine levels. Korkmaz ME; Atar I; Tayfun E; Yildirir A; Ulucam M; Ozin B; Muderrisoglu H; Turan M Int J Cardiol; 2003 Mar; 88(1):119-20. PubMed ID: 12659999 [No Abstract] [Full Text] [Related]
11. Eplerenone for the treatment of cardiovascular disorders. Watanabe M; Krum H Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):831-8. PubMed ID: 22908915 [TBL] [Abstract][Full Text] [Related]
12. The role of aldosterone receptor antagonists in the management of heart failure: an update. Nagarajan V; Chamsi-Pasha M; Tang WH Cleve Clin J Med; 2012 Sep; 79(9):631-9. PubMed ID: 22949344 [TBL] [Abstract][Full Text] [Related]
13. Aldosterone blockade in patients with systolic left ventricular dysfunction. Pitt B Circulation; 2003 Oct; 108(15):1790-4. PubMed ID: 14557343 [No Abstract] [Full Text] [Related]
14. Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome. Costa MB; Andrade Ezequiel DG; Morais Lovis JC; Oliveira MM; Baumgratz de Paula R J Clin Hypertens (Greenwich); 2010 Sep; 12(9):753-5. PubMed ID: 20883238 [No Abstract] [Full Text] [Related]
15. Evolving strategies for the use of spironolactone in cardiovascular disease. Jolobe OM Eur J Intern Med; 2013 Jun; 24(4):303-9. PubMed ID: 23245930 [TBL] [Abstract][Full Text] [Related]
16. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling]. Tatsumi T; Matsubara H Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886 [No Abstract] [Full Text] [Related]
17. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker. Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523 [TBL] [Abstract][Full Text] [Related]